Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TGFβRI-IN-3 inhibits TGFβR1 with an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4. TGFβRI-IN-3 is a highly selective TGFβR1 inhibitor that has potential applications in immuno-oncology [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 80.00 | |
5 mg | In stock | $ 197.00 | |
10 mg | In stock | $ 313.00 | |
25 mg | In stock | $ 613.00 | |
50 mg | In stock | $ 955.00 | |
100 mg | In stock | $ 1,370.00 | |
500 mg | In stock | $ 2,730.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 197.00 |
Description | TGFβRI-IN-3 inhibits TGFβR1 with an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4. TGFβRI-IN-3 is a highly selective TGFβR1 inhibitor that has potential applications in immuno-oncology [1]. |
In vitro | TGFβRI-IN-3 inhibits TGFβR1 at an IC 50 of 0.79 nM, 2000-fold selectivity for MAP4K4 [1]. |
Molecular Weight | 465.57 |
Formula | C28H23N3O2S |
CAS No. | 2763602-67-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (107.40 mM), Sonification and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TGFβRI-IN-3 2763602-67-9 Stem Cells TGF-beta/Smad TGFβRI IN 3 TGFβRIIN3 TGFbetaRI-IN-3 TGFbRI-IN-3 inhibitor inhibit